| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.19▲ | 1.20▼ | 1.20▼ | 1.21▼ | 1.24▼ |
| MA10 | 1.21▼ | 1.21▼ | 1.21▼ | 1.23▼ | 1.22▼ |
| MA20 | 1.22▼ | 1.23▼ | 1.23▼ | 1.24▼ | 1.25▼ |
| MA50 | 1.23▼ | 1.24▼ | 1.24▼ | 1.20▼ | 1.74▼ |
| MA100 | 1.24▼ | 1.22▼ | 1.21▼ | 1.29▼ | 1.85▼ |
| MA200 | 1.20▼ | 1.20▼ | 1.19▲ | 1.73▼ | 1.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.005▼ | -0.005▼ | -0.009▼ | 0.030▲ |
| RSI | 44.819▼ | 45.556▼ | 45.811▼ | 47.056▼ | 43.131▼ |
| STOCH | 23.611 | 25.278 | 31.875 | 25.418 | 59.876 |
| WILL %R | -68.750 | -68.750 | -72.222 | -83.333▼ | -56.812 |
| CCI | -74.667 | -63.830 | -81.417 | -96.384 | -38.396 |
|
Sunday, May 31, 2026 05:00 PM
Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, May 28, 2026 06:04 AM
Abstract Title: Pre-Clinical Results for EB612: First-in-Class Oral Long-Acting PTH (1-34) Analog as Hormone Replacement Tablet for Patients with Hypoparathyroidism Session Date/Time: Monday, June 15, ...
|
|
Tuesday, May 26, 2026 04:59 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/06/26 | 1.195 | 1.195 | 1.195 | 1.195 | 16,381 |
| 05/06/26 | 1.19 | 1.22 | 1.16 | 1.18 | 60,295 |
| 04/06/26 | 1.20 | 1.238 | 1.20 | 1.22 | 53,288 |
| 03/06/26 | 1.22 | 1.24 | 1.195 | 1.22 | 44,155 |
| 02/06/26 | 1.25 | 1.2599 | 1.18 | 1.25 | 132,044 |
| 01/06/26 | 1.34 | 1.37 | 1.2401 | 1.27 | 104,659 |
| 29/05/26 | 1.22 | 1.37 | 1.21 | 1.35 | 167,977 |
| 28/05/26 | 1.20 | 1.23 | 1.20 | 1.22 | 75,479 |
| 27/05/26 | 1.21 | 1.21 | 1.18 | 1.19 | 189,784 |
| 26/05/26 | 1.24 | 1.255 | 1.21 | 1.21 | 30,143 |
|
|
||||
|
|
||||
|
|